Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 02.07.2025. Verfasst von Tatsuro Nakamura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Midazolam, Neoplasms, Hypnotics and Sedatives, Ketamine. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Children with developmental disabilities (DDs) tend to have more fear of loud noises and needles than those without. However, how DDs affect sedation during painful procedures in pediatric patients with cancer is unclear. This study aimed to evaluate the sedative doses and adverse events (AEs) associated with sedation using a combination of midazolam and ketamine for bone marrow aspiration and intrathecal therapy.
Methods
The AEs evaluated included hypoxia, vomiting, tremors, excitement, disturbances, apnea, and bradycardia. The study included seven participants with autism spectrum disorder, attention deficit hyperactivity disorder, and specific learning disorders, alongside 30 control participants without DD. The types of cancers included acute lymphoblastic leukemia, acute myeloid leukemia, and diffuse large B‐cell lymphoma. A total of 107 procedures were performed in the DD group and 378 in the control group.
Results
There were no significant differences in the sedative doses and AEs between patients with DD and controls, except for increased tremors after sedation in the DD group.
Conclusions
Sedation using a combination of midazolam and ketamine can be safely performed for painful procedures in pediatric patients with cancer and DD without excessive concern.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
ORCID-Profile: Tatsuro Nakamura, Yuki Yasudome, Yuichi Kodama, Takuro Nishikawa, Yasuhiro Okamoto
Zitieren
APA
Nakamura, T., Nakagawa, S., Horikawa, S., Nagahama, J., Yasudome, Y., Abematsu, T., Kodama, Y., Nishikawa, T., & Okamoto, Y. (2025). Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70142
Vancouver
Nakamura T, Nakagawa S, Horikawa S, Nagahama J, Yasudome Y, Abematsu T, et al. Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities. Pediatrics International. 2025;67(1). doi:10.1111/ped.70142
BibTeX
@article{Nakamura2025,
author = {Nakamura, Tatsuro and Nakagawa, Shunsuke and Horikawa, Shogo and Nagahama, Jun and Yasudome, Yuki and Abematsu, Takanari and Kodama, Yuichi and Nishikawa, Takuro and Okamoto, Yasuhiro},
title = {Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70142}
}
EUVIMED